INTRODUCTION: At Alcon, our surgical medical device products, such as the AcrySof® IQ Vivity™ Extended Vision Intraocular Lens (IOL), are designed, manufactured and marketed with a body of science developed through rigorous bench research and clinical studies. As the body of knowledge behind Alcon’s products grows, so does the challenge of making our customers aware of its depth. Our medical affairs organization is thus focused on both high-quality data generation and its communication to the clinical community. High-quality scientific publications are essential to convey the clinical community’s knowledge and experience with new technology. This clinical science compendium provides a consolidated view of peer-reviewed articles evaluating the bench performance and clinical characteristics of the AcrySof® IQ Vivity™ IOL*. METHODOLOGY: The compendium includes peer-reviewed articles published in English before June 22, 2023 involving the AcrySof® IQ Vivity™ IOL. The research included bench studies assessing the performance of the AcrySof® IQ Vivity™ IOL, as well as clinical studies examining outcomes in patients receiving surgical implantation of the IOL. For devices that have not been approved by Health Canada, their data have not been included.